Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Uma Siddhartha Nayak"'
Autor:
Ashwani Sood, Monjori Mitra, Himanshu Arvind Joshi, Uma Siddhartha Nayak, Prashanth Siddaiah, T. Ramesh Babu, Samarendra Mahapatro, Jayesh Sanmukhani, Gaurav Gupta, Ravindra Mittal, Reinhard Glueck
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 7, Pp 1523-1530 (2017)
This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s Cadila Healthcare Limited, India (Cadila MMR vaccine), c
Externí odkaz:
https://doaj.org/article/b9ae060bc0ff4ee48c1371088e2ac6db
Autor:
Jayesh Sanmukhani, Uma Siddhartha Nayak, Himanshu Arvind Joshi, Ravindra Mittal, Prashanth Siddaiah, Samarendra Mahapatro, Ashwani Sood, Monjori Mitra, Gaurav Gupta, T Ramesh Babu, Reinhard Glueck
Publikováno v:
Human Vaccines & Immunotherapeutics
This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s Cadila Healthcare Limited, India (Cadila MMR vaccine), c
Autor:
Ravindra Mittal, Jayesh Sanmukhani, Neeta Hanumante, Uma Siddhartha Nayak, Paresh Thakkar, Rajesh Joshi, Shalaka Agarkhedkar
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 1, Pp SC09-SC13 (2018)
Introduction: This is the first study in Indian paediatric subjects to evaluate the novel Measles, Mumps and Rubella (MMR) vaccine developed by M/s Cadila Healthcare Limited, India, containing the Hoshino mumps strain. This phase II study was done as